Association of the C677T polymorphism in the MTHFR gene with migraine: A meta-analysis

Cephalalgia

Volumn 29, Issue 8, 2009, Pages 818-825

  Rubino, E ^a   Ferrero, M ^a   Rainero, I ^a   Binello, E ^a   Vaula, G ^a   Pinessi, L ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Association; Aura; Meta analysis; Migraine; MTHFR; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; ENZYME ACTIVITY; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; META ANALYSIS; MIGRAINE WITH AURA; MTHFR GENE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 67650311784     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01400.x     Document Type: Article

References (39)

1. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache 1994 34 : 319 28.
2. Hagen K, Zwart JA, Vatten L, Stovner LJ, Bovim G. Prevalence of migraine and non-migrainous headache - head-HUNT, a large population-based study. Cephalalgia 2000 20 : 900 6.
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 8 (Suppl. 7 1 96.
4. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol 1999 45 : 242 6.
5. Terwindt GM, Haan J, Ophoff RA, Frants RR, Ferrari MD. The quest for migraine genes. Curr Opin Neurol 1997 10 : 221 5.
6. Ducros A, Tournier-Lasserve E, Bousser MG. The genetics of migraine. Lancet Neurol 2002 1 : 285 93.
7. Buzzi MG, Moskowitz MA. The pathophysiology of migraine: year 2005. J Headache Pain 2005 6 : 105 11.
8. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 1994 7 : 551.
9. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 1997 78 : 523 6.
10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995 10 : 111 3.
11. Cronin S, Furie KL, Kelly PJ. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 2005 36 : 1581 7.
12. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C - >T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002 288 : 2023 31.
13. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 2006 16 : 105 15.
14. Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorder: A HuGE Review. Am J Epidemiol 2007 165 : 1 13. (Pubitemid 46026203)
15. Lewis SJ, Lawlor DA, Davey Smith G, Araya R, Timpson N, Day IN, et al. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry 2006 11 : 352 60.
16. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000 96 : 762 4.
17. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003 111 : 84 90. (Pubitemid 36332332)
18. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2004 2 : 3.
19. Oterino A, Valle N, Bravo Y, Muñoz P, Sánchez-Velasco P, Ruiz-Alegría C, et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia 2004 24 : 491 4.
20. Oterino A, Valle N, Pascual J, Bravo Y, Muñoz P, Castillo J, et al. Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 allele. Brain Res Mol Brain Res 2005 139 : 163 8.
21. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006 59 : 372 5.
22. Todt U, Freudenberg J, Goebel I, Netzer C, Heinze A, Heinze-Kuhn K, et al. MTHFR C677T polymorphism and migraine with aura. Ann Neurol 2006 60 : 621 2.
23. Kaunisto M, Kallela M, Hamalainen E, Kilpikari R, Havanka H, Harno H, et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 2006 26 : 1462 72.
24. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet 2004 20 : 439 44.
25. Bottini F, Celle ME, Calevo MG, Amato S, Minniti G, Montaldi L, et al. Metabolic and genetic risk factors for migraine in children. Cephalalgia 2006 26 : 731 7.
26. Wessman M, Kaunisto MA, Kallela M, Palotie A. The molecular genetics of migraine. Ann Med 2004 36 : 462 73.
27. Zintzaras E, Ioannidis JP. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 2005 21 : 3672 3.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 327 : 557 60.
29. Zintzaras E, Hadjigeorgiou GM. The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis. J Hum Genet 2005 50 : 560 6.
30. Ashfield-Watt PA, Pullin CH, Whiting JM, Clark ZE, Moat SJ, Newcombe RG et al. Methylenetetrahydrofolate reductase 677C>T genotype modulates homocysteine response to a folate-rich diet or a low-dose folic acid (Suppl.): a randomized controlled trial. Am J Clin Nutr 2002 76 : 180 6.
31. Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998 62 : 1258 60.
32. Franco RF, Araujo AG, Guerreiro JF, Elion J, Zago MA. Analysis of the 677 C - >T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 1998 79 : 119 21.
33. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol 2005 18 : 305 10.
34. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005 330 : 63.
35. Evers S, Koch HG, Husstedt IW. Plasma homocysteine levels in primary headache. In : Olesen J, Edvinsson L, editors. Headache Pathogenesis: Monoamines, Neuropetides, Purines and Nitric Oxide. Philadelphia : Lippincott-Raven Publishers 1997 : 215 8.
36. Storer RJ, Goadsby PJ. Microiontophoretic application of serotonin (5HT) 1B-1D agonists inhibits trigeminal cell firing in the cat. Brain 1997 120 : 2171 7.
37. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994 44 : S17 22.
38. Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in community sample: results from the Balitmore Epidemiologic Catchment area follow-up study. Arch General Psychiatry 2000 57 : 945 50.
39. Oedegaard KJ, Neckelmann D, Mykletun A, Dahl AA, Zwart JA, Hagen K, Fasmer OB. Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 2006 26 : 1 6.